Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (127)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Haines, J. L.
Right arrow Articles by Hauser, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haines, J. L.
Right arrow Articles by Hauser, S. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 7, 1229-1234, Copyright © 1998 by Oxford University Press

ARTICLES

Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group

JL Haines, HA Terwedow, K Burgess, MA Pericak-Vance, JB Rimmler, ER Martin, JR Oksenberg, R Lincoln, DY Zhang, DR Banatao, N Gatto, DE Goodkin and SL Hauser
Molecular Neurogenetics Unit, Massachusetts General Hospital, Boston, MA, USA. jonathan@ruth.mc.vanderbilt.edu

Multiple sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system. While its etiology is not well understood, genetic factors are clearly involved. Until recently, most genetic studies in MS have been association studies using the case-control design testing specific candidate genes and studying only sporadic cases. The only consistently replicated finding has been an association with the HLA-DR2 allele within the major histocompatibility complex (MHC) on chromosome 6. Using the genetic linkage design, however, evidence for and against linkage of the MHC to MS has been found, fostering suggestions that sporadic and familial MS have different etiologies. Most recently, two of four genomic screens demonstrated linkage to the MHC, although specific allelic associations were not tested. Here, a dataset of 98 multiplex families was studied to test for an association to the HLA-DR2 allele in familial MS and to determine if genetic linkage to the MHC was due solely to such an association. Three highly polymorphic markers (HLA-DR, D6S273 and TNFbeta) in the MHC demonstrated strong genetic linkage (parametric lod scores of 4.60, 2.20 and 1.24, respectively) and a specific association with the HLA-DR2 allele was confirmed (TDT; P < 0.001). Stratifying the results by HLA-DR2 status showed that the linkage results were limited to families segregating HLA-DR2 alleles. These results demonstrate that genetic linkage to the MHC can be explained by the HLA-DR2 allelic association. They also indicate that sporadic and familial MS share a common genetic susceptibility. In addition, preliminary calculations suggest that the MHC explains between 17 and 62% of the genetic etiology of MS. This heterogeneity is also supported by the minority of families showing no linkage or association with loci within the MHC.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mult SclerHome page
E Cocco, C Sardu, R Murru, J Frau, L Lorefice, E Mamusa, P Contu, and M. Marrosu
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population
Multiple Sclerosis, September 1, 2009; 15(9): 1030 - 1036.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
M. J. Chao, S. V. Ramagopalan, B. M. Herrera, M. R. Lincoln, D. A. Dyment, A. D. Sadovnick, and G. C. Ebers
Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex
Hum. Mol. Genet., January 15, 2009; 18(2): 261 - 266.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. T. Okuda, R. Srinivasan, J. R. Oksenberg, D. S. Goodin, S. E. Baranzini, A. Beheshtian, E. Waubant, S. S. Zamvil, D. Leppert, P. Qualley, et al.
Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures
Brain, January 1, 2009; 132(1): 250 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. J. Chao, M. C. N. M. Barnardo, M. R. Lincoln, S. V. Ramagopalan, B. M. Herrera, D. A. Dyment, A. Montpetit, A. D. Sadovnick, J. C. Knight, and G. C. Ebers
HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility
PNAS, September 2, 2008; 105(35): 13069 - 13074.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
T. Vyshkina and B. Kalman
Linkage disequilibrium analyses within chromosome 19p in multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 433 - 439.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
M. J. Chao, M. C.N.M. Barnardo, G.-z. Lui, M. R. Lincoln, S. V. Ramagopalan, B. M. Herrera, D. A. Dyment, A. D. Sadovnick, and G. C. Ebers
Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium
Hum. Mol. Genet., August 15, 2007; 16(16): 1951 - 1958.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
H. Schmidt, D. Williamson, and A. Ashley-Koch
HLA-DR15 Haplotype and Multiple Sclerosis: A HuGE Review
Am. J. Epidemiol., May 15, 2007; 165(10): 1097 - 1109.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M. Callander, S. Haghighi, A.-M. Landtblom, C.E. Ahlgren, S.I. Nilsson, L. Rydberg, H. Al Khoury, L. Rosengren, and O. Andersen
Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis
Multiple Sclerosis, May 1, 2007; 13(4): 441 - 445.
[Abstract] [PDF]

Home page
 Mult SclerHome page
S Haghighi, O Andersen, S Nilsson, L Rydberg, and J Wahlstrom
A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy
Multiple Sclerosis, November 1, 2006; 12(6): 723 - 730.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
L. F. Barcellos, S. Sawcer, P. P. Ramsay, S. E. Baranzini, G. Thomson, F. Briggs, B. C.A. Cree, A. B. Begovich, P. Villoslada, X. Montalban, et al.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
Hum. Mol. Genet., September 15, 2006; 15(18): 2813 - 2824.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. M. Burwick, P. P. Ramsay, J. L. Haines, S. L. Hauser, J. R. Oksenberg, M. A. Pericak-Vance, S. Schmidt, A. Compston, S. Sawcer, R. Cittadella, et al.
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers
Neurology, May 9, 2006; 66(9): 1373 - 1383.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. A. Dyment, B. M. Herrera, M. Z. Cader, C. J. Willer, M. R. Lincoln, A. D. Sadovnick, N. Risch, and G. C. Ebers
Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance
Hum. Mol. Genet., July 15, 2005; 14(14): 2019 - 2026.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. Brassat, G. Salemi, L. F. Barcellos, G. McNeill, P. Proia, S. L. Hauser, J. R. Oksenberg, and G. Savettieri
The HLA locus and multiple sclerosis in Sicily
Neurology, January 25, 2005; 64(2): 361 - 363.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
H. Hjalgrim, S. Rasmussen, K. Rostgaard, N. M. Nielsen, N. Koch-Henriksen, L. Munksgaard, H. H. Storm, and M. Melbye
Familial Clustering of Hodgkin Lymphoma and Multiple Sclerosis
J Natl Cancer Inst, May 19, 2004; 96(10): 780 - 784.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D.-A. Laplaud, C. Ruiz, S. Wiertlewski, S. Brouard, L. Berthelot, M. Guillet, B. Melchior, N. Degauque, G. Edan, P. Brachet, et al.
Blood T-cell receptor {beta} chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution
Brain, May 1, 2004; 127(5): 981 - 995.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Zhou, K. Rammohan, S. Lin, N. Robinson, O. Li, X. Liu, X.-f. Bai, L. Yin, B. Scarberry, P. Du, et al.
CD24 is a genetic modifier for risk and progression of multiple sclerosis
PNAS, December 9, 2003; 100(25): 15041 - 15046.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Karlsson, X. Zhao, I. Lonskaya, M. Neptin, R. Holmdahl, and A. Andersson
Novel Quantitative Trait Loci Controlling Development of Experimental Autoimmune Encephalomyelitis and Proportion of Lymphocyte Subpopulations
J. Immunol., January 15, 2003; 170(2): 1019 - 1026.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
The Multiple Sclerosis Genetics Group, J. L. Haines, Y. Bradford, M. E. Garcia, A. D. Reed, E. Neumeister, M. A. Pericak-Vance, J. B. Rimmler, M. M. Menold, E. R. Martin, et al.
Multiple susceptibility loci for multiple sclerosis
Hum. Mol. Genet., September 15, 2002; 11(19): 2251 - 2256.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. A. de Jong, T. W.J. Huizinga, E. Zanelli, M. J. Giphart, E. L.E.M. Bollen, B. M.J. Uitdehaag, C. H. Polman, and R. G.J. Westendorp
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region
Neurology, August 27, 2002; 59(4): 549 - 555.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A E Hensiek, S J Sawcer, R Feakes, J Deans, A Mander, E Akesson, R Roxburgh, F Coraddu, S Smith, and D A S Compston
HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 184 - 187.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
The Multiple Sclerosis Genetics Group, L. F. Barcellos, J. R. Oksenberg, A. J. Green, P. Bucher, J. B. Rimmler, S. Schmidt, M. E. Garcia, R. R Lincoln, M. A. Pericak-Vance, et al.
Genetic basis for clinical expression in multiple sclerosis
Brain, January 1, 2002; 125(1): 150 - 158.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. D. Bird, G. P. Jarvik, and N. W. Wood
Genetic association studies: Genes in search of diseases
Neurology, October 9, 2001; 57(7): 1153 - 1154.
[Full Text] [PDF]

Home page
 Mult SclerHome page
The Transatlantic Multiple Sclerosis Genetics Coop
A meta-analysis of genomic screens in multiple sclerosis
Multiple Sclerosis, February 1, 2001; 7(1): 3 - 11.
[Abstract] [PDF]

Home page
 NeurologyHome page
C. Alvarado-de la Barrera, J. Zuniga-Ramos, J. A. Ruiz-Morales, B. Estanol, J. Granados, and L. Llorente
HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis
Neurology, December 26, 2000; 55(12): 1897 - 1900.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker
Multiple Sclerosis
N. Engl. J. Med., September 28, 2000; 343(13): 938 - 952.
[Full Text] [PDF]

Home page
 Mult SclerHome page
P. Hugh, A. Oturai, K. Schreiber, M. Blinkenberg, O. S. Jurgensen, L. Ryder, O. B Paulson, P. S. Surensen, and G. M. Knudsen
Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate
Multiple Sclerosis, August 1, 2000; 6(4): 226 - 230.
[Abstract] [PDF]

Home page
 NeurologyHome page
S. L. Hauser, J. R. Oksenberg, R. Lincoln, J. Garovoy, R. W. Beck, S. R. Cole, P. S. Moke, K. E. Kip, R. L. Gal, and D. T. Long
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS
Neurology, May 9, 2000; 54(9): 1859 - 1861.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
Q R Huang, S M Teutsch, M M. Buhler, B H Bennetts, R N. Heard, N Manolios, and G J Stewart
Evaluation of the Apo-1/Fas promoter Mva I polymorphism in multiple sclerosis
Multiple Sclerosis, February 1, 2000; 6(1): 14 - 18.
[Abstract] [PDF]

Home page
 Mult SclerHome page
A Karni, Y Kohn, C Saftirmnn, O Abraimsky, L Barcellos, J R Oksenberg, E Kahana, D Karussis, J Chapman, and C Brautbur
Evidence for the genetic role of human leukocyte antigens in low frequency DRBI*1501 multiple sclerosis patients in Israel
Multiple Sclerosis, December 1, 1999; 5(6): 410 - 415.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.